Artiva Biotherapeutics, Inc. Intellectual Property Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Selected Product License Agreement (AB-201), dated September 6, 2023, by and between the Registrant and GC Cell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2024
Selected Product License Agreement (AB-201), dated September 29, 2020, by and between the Registrant and GC Cell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2024
Selected Product License Agreement (AB-101), dated November 21, 2019, by and between the Registrant and GC Cell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2024
Amendment No. 1 to Option and License Agreement, dated June 23, 2020, by and between the Registrant and GC Cell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2024
Option and License Agreement, dated September 4, 2019, by and between the Registrant and GC Cell Corporation (f/k/a GC Lab Cell Corporation)
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
NY
2024
First Amendment to License Agreement, dated May 9, 2022, by and between the Registrant and ARE-SD Region No. 37, LLC
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2022
Selected Product License Agreement (AB-202), dated March 24, 2021, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Merck Partnered Product Research Services and License Agreement, dated January 27, 2021, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
NY
2021
Selected Product License Agreement (AB-201), dated September 29, 2020, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Selected Product License Agreement (AB-101), dated November 21, 2019, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Amendment No. 1 to Option and License Agreement, dated June 23, 2020, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
2021
Option and License Agreement, dated September 4, 2019, by and between the Registrant and Green Cross LabCell Corporation
License Agreements
Artiva Biotherapeutics, Inc.
Biotechnology
NY
2021